A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Status:
Recruiting
Trial end date:
2026-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in
participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK
master protocol) including a subset of participants who have obstructive sleep apnea (OSA)
(J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.